Returns–Not enough quarters yet
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| CGONCg Oncology Inc | $452.7M | 61.9% | |
| NUVBNuvation Bio Inc. | $147.4M | 20.1% | |
| AARDAardvark Therapeutics Inc | $22.6M | 3.1% | |
| ACRSAclaris Therapeutics, Inc. | $21.4M | 2.9% | |
| UPBUpstream Bio Inc. | $18.9M | 2.6% | |
| RCUSArcus Biosciences, Inc | $14.3M | 2.0% | −2.7% |
| EQEquillium Inc. | $14.2M | 1.9% | |
| RVMDRevolution Medicines Inc(nsm) | $9.9M | 1.3% | −43.7% |
| Lyell Immunopharma, Inc.CUSIP 55083R104 | $9.7M | 1.3% | |
| BeyondSpring Inc.CUSIP G10830100 | $6.7M | 0.9% | |
| ZNTLZentalis Pharmaceuticals Inc. | $6.4M | 0.9% | |
| Newamsterdam Pharma Co NvCUSIP N62509109 | $6.0M | 0.8% | −45.6% |
| PYXSPyxis Oncology, Inc (formerly Apexigen) | $984K | 0.1% | |
| TNGXTango Therapeutics Inc | $625K | 0.1% | New |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| RVMDRevolution Medicines Inc(nsm) | September 30, 2024 | +313.0% | $9.9M |
| ACRSAclaris Therapeutics, Inc. | December 31, 2024 | +113.3% | $21.4M |
| NUVBNuvation Bio Inc. | June 30, 2024 | +94.5% | $147.4M |
| Newamsterdam Pharma Co NvCUSIP N62509109 | June 30, 2024 | +76.4% | $6.0M |
| PYXSPyxis Oncology, Inc (formerly Apexigen) | December 31, 2023 | +67.2% | $984K |
| CGONCg Oncology Inc | March 31, 2024 | +61.8% | $452.7M |
| RCUSArcus Biosciences, Inc | December 31, 2023 | +61.4% | $14.3M |
Sold off last quarter
- KRYSKrystal Biotech Inc was $1.9M
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +13.9% | +14.8% |
| December 31, 2025 | +34.6% | +2.4% |
| September 30, 2025 | +47.7% | +7.8% |
| June 30, 2025 | +15.3% | +10.5% |
| March 31, 2025 | −25.8% | −4.6% |
| December 31, 2024 | −14.1% | +2.1% |
| September 30, 2024 | +11.2% | +5.4% |
| March 31, 2024 | +35.9% | +10.0% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Decheng Capital LLC Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2010850&type=13F-HR&dateb=&owner=include&count=40CIK 2010850
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/2010850/000110465926096837/Filed August 14, 2026 · accession 0001104659-26-096837